CTIS2023-503763-42-00进行中（未招募）1 期
A Phase 3, Randomized, Observer-Blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of a High-Dose MF59-Adjuvanted Quadrivalent Subunit Cell-derived Influenza Vaccine (aQIVc HD) in Comparison with a Non-adjuvanted Quadrivalent Recombinant Influenza Vaccine (QIVr) and an MF59-Adjuvanted Quadrivalent Subunit Egg-derived Influenza Vaccine (aQIV), in Adults Aged 50 Years and Older. - V201_03
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 6,300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 65+（—）
- 性别
- All
入选标准
- •Individuals, aged 50 years and older, who are healthy or have stable comorbidities that increase their risk of complications from influenza infection, Individuals who can comply with all study procedures
排除标准
- •Progressive, unstable, or uncontrolled clinical conditions, Known hypersensitivity or allergy to any study vaccine component, Known history of Guillain-Barré syndrome or other demyelinating disease, Condition representing a contraindication to vaccination or blood draw, Abnormal function of immune system due to know disorder or medication, Influenza vaccination within 180 days prior to informed consent or plan to receive influenza vaccine within 9 months from study vaccination (all subjects) or within 12 months (subjects in the long-term subset for immunogenicity)..
研究者
相似试验
进行中（未招募）
1 期
A Phase 3, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of Single Dose of Novartis Meningococcal ACWY Conjugate Vaccine, administered to Healthy Toddlers 12 Months of Age, Compared to Single Dose of Meningococcal C Conjugate VaccineTo demonstrate non-inferiority of MenACWY vaccine to that of MenC vaccinegiven to healthy toddlers, as measured by the percentage of subjects with serumbactericidal assay using human complement (hSBA) titers =8 against N.meningitidis serogroup C, at 28 days after the vaccination.MedDRA version: 16.0Level: PTClassification code 10027202Term: Meningitis bacterialSystem Organ Class: 10021881 - Infections and infestationsEUCTR2013-000145-39-CZovartis Vaccines and Diagnostics s.r.l1,000
进行中（未招募）
不适用
A Phase 3, Randomized, Controlled, Observer-Blind, Multi-Center Study Assessing the Immunogenicity and Safety of Single Dose of Novartis Meningococcal ACWY Conjugate Vaccine, administered to Healthy Toddlers 12 Months of Age, Compared to Single Dose of Meningococcal C Conjugate VaccineEUCTR2013-000145-39-ITovartis Vaccines and Diagnostics s.r.l1,000
进行中（未招募）
不适用
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adultsovartis Meningococcal ACWY conjugate vaccine is intended for prevention of meningitis and septicemia caused by Neisseria meningitidis serogroups A, C, W and Y.MedDRA version: 17.1Level: PTClassification code 10027280Term: Meningococcal sepsisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: PTClassification code 10027249Term: Meningitis meningococcalSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: LLTClassification code 10027276Term: Meningococcal meningitisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: PTClassification code 10027274Term: Meningococcal infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: LLTClassification code 10040081Term: Septicaemia meningococcalSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 17.1Level: LLTClassification code 10040048Term: Sepsis meningococcalSystem Organ Class: 10021881 - Infections and infestationsEUCTR2014-003504-79-Outside-EU/EEAovartis Vaccines & Diagnostics, Inc.3,539
进行中（未招募）
1 期
Clinical study in adults 50-64 years old to evaluate immunogenicity and safety of adjuvanted flu vaccine in comparison with a licensed non-adjuvanted flu vaccineProphylaxis of InfluenzaMedDRA version: 20.0Level: PTClassification code 10022000Term: InfluenzaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-001721-40-DESeqirus UK Limited2,018
进行中（未招募）
不适用
Safety and Immunogenicity of Meningococcal ACWY Conjugate Versus Polysaccharide Vaccine in Children 2 to 10 Years of AgeEUCTR2014-003514-91-Outside-EU/EEAovartis Vaccines and Diagnostics S.r.l.1,500